子宫肌瘤保守治疗:随机对照研究的网络Meta分析
该网络Meta分析纳入2000至2024年间10项随机试验共1002例受试者,比较子宫动脉栓塞术(UAE)、高强度聚焦超声(HIFU)、射频消融治疗(RFT)与腹腔镜/开腹手术保守治疗子宫肌瘤的效果。结果显示子宫肌瘤剔除术的再干预及后续子宫切除风险最低,HIFU的主要并发症风险最低。
要点
- 子宫肌瘤剔除术随访期间再干预风险最低(SUCRA 98%),UAE与HIFU再干预率显著高于剔除术。
- HIFU主要并发症风险最低(SUCRA 81.5%),UAE主要并发症风险显著低于剔除术(OR 0.38)。
- 各治疗间生活质量评估无差异,但模型异质性高且不一致。
核心结论
- 在随机试验分析中,子宫肌瘤剔除术在相对较短的随访期内再干预及后续子宫切除风险最低。
- HIFU是主要并发症风险最低的方法。
研究设计与样本
- 网络Meta分析,纳入2000至2024年间10项随机试验共1002例随机受试者,检索PubMed、Embase和Cochrane Library数据库,遵循PRISMA标准。
- 使用R软件netmeta子程序进行网络Meta分析,采用Revised Cochrane随机试验偏倚风险评估工具评价偏倚风险,并通过贝叶斯网络Meta分析计算累积排名曲线下面积(SUCRA)。
主要发现
- 每100人年随访的再干预发生率:子宫肌瘤剔除术4.13(范围0-19.4),UAE 16.1(6.2-32.8),HIFU 14.3(0-15.1),RFT 6(4.3-6.7)。
- 与子宫肌瘤剔除术相比的再干预发生率比:UAE 2.45(95%CI 1.38-4.37),HIFU 5.23(95%CI 1.59-17.3),RFT 4.59(95%CI 0.77-27.3;p=.09)。
- 随访期间(中位12个月,范围3-24)再干预或子宫切除风险:RFT的SUCRA最高(1.25%和3%),子宫肌瘤剔除术最低(SUCRA 98%和95%)。
- 主要并发症风险:UAE显著低于子宫肌瘤剔除术(OR 0.38;95%CI 0.17-0.85);HIFU主要并发症可能性最低(SUCRA 81.5%)。
- 随访时生活质量评估各治疗间无差异,但模型高度异质且不一致。
临床怎么用
- 原文未据此给出推荐。
局限性
- 随访期相对较短。
- 生活质量评估模型高度异质且不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To comparatively evaluate the effectiveness of uterine artery embolization (UAE), high-intensity focused ultrasound (HIFU), radiofrequency ablation treatment (RFT), and laparoscopic/laparotomic surgery in the conservative treatment of uterine fibroids. DATA SOURCES: The research was performed via electronic databases PubMed, Embase, and Cochrane Library, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards. METHODS OF STUDY SELECTION: The network included 10 randomized trials between 2000 and 2024 and 1002 randomized subjects. TABULATION, INTEGRATIONS, AND RESULTS: The network meta-analysis was conducted with subroutine netmeta on R. The risk of bias was assessed using the Revised Cochrane risk-of-bias tool for randomized trials. The surface under the cumulative ranking curve (SUCRA) was computed by Bayesian network meta-analysis. Incidences of reintervention per 100 person/year of follow-up were 4.13 (range, 0-19.4), 16.1 (6.2-32.8), 14.3 (0-15.1), and 6 (4.3-6.7) for myomectomy, UAE, HIFU, and RFT, respectively. The incidence rate ratios compared with myomectomy were 2.45 (95% confidence interval [CI], 1.38-4.37), 5.23 (95% CI, 1.59-17.3), and 4.59 (95% CI, 0.77-27.3; p = .09) for UAE, HIFU, and RFT, respectively. RTF had the highest (SUCRA, 1.25% and 3%) whereas myomectomy had the lowest risk of reintervention (SUCRA, 98% and 95%) or hysterectomy during follow-up (median, 12 months; range, 3-24). The risk of major complications was significantly lower after UAE (odds ratio, 0.38; 95% CI, 0.17-0.85) than myomectomy. The procedure with the lowest likelihood of major complications was HIFU (SUCRA, 81.5%). Finally, in the evaluation of QoL at follow-up visits, there were no differences between the treatments studied, although the model was highly heterogeneous and inconsistent. CONCLUSION: In the analysis of randomized trials, surgical myomectomy carried the least risk of reintervention and subsequent hysterectomy during a relatively short follow-up period. HIFU was the method with the lowest risk of major complications.
引用
- Dominoni M, Gardella B, Gritti A, et al. Conservative Treatment of Uterine Myomas: A Network Meta-Analysis of Randomized Controlled Studies. J Minim Invasive Gynecol. 2024. PMID: 39733851. doi:10.1016/j.jmig.2024.12.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。